Health
Personalized genetic testing helps reduce adverse events following balloon angioplasty – News-Medical.Net
An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by 34 per cent the number of serious adverse events following balloon angioplasty, a treatment for the most common form of heart disease.
An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by 34 percent the number of serious adverse events following balloon angioplasty, a treatment for the most common form of heart disease.
For patients undergoing percutaneous coronary intervention (PCI)-; a non-surgical procedure where physicians inflate a balloon and place a metal stent in narrowed heart arteries to improve blood flow to the heart-;the choice of antiplatelet therapy can be critical …
-
Noosa News17 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General18 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business23 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock
-
General23 hours agoStocks, dollar sink as trade war roils markets